EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway

Tanapon Soonthonsrima iD, Ismail Dwi Putra, Preeyaphan Phookphan, Zin Zin Ei, Masashi Yokoya iD, Pithi Chanvorachote iD

Chemical Research in Toxicology · 2025

DOI: 10.1021/acs.chemrestox.4c00436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2025. Verfasst von Tanapon Soonthonsrima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand. Hauptthemen laut MEDLINE: Resveratrol, Signal Transduction, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Council of Thailand, Chulalongkorn University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolSignal TransductionCarcinoma, Non-Small-Cell LungLung NeoplasmsErb-b2 Receptor Tyrosine KinasesNeoplastic Stem CellsAntineoplastic AgentsHumansCell ProliferationStructure-Activity RelationshipMolecular Docking SimulationDrug Screening Assays, AntitumorApoptosisMolecular StructureCell Line, Tumor

Substanzen

ResveratrolErb-b2 Receptor Tyrosine KinasesAntineoplastic AgentsERBB2 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Pharmaceutical Sciences and Technology Graduate Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.
  • Department of Pharmaceutical Chemistry, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan.

ORCID-Profile: Tanapon Soonthonsrima, Masashi Yokoya, Pithi Chanvorachote

Förderung

  • National Research Council of Thailand
  • Chulalongkorn University

Zitieren

APA

Soonthonsrima, T., Putra, I. D., Phookphan, P., Ei, Z. Z., Yokoya, M., & Chanvorachote, P. (2025). A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.4c00436

Vancouver

Soonthonsrima T, Putra ID, Phookphan P, Ei ZZ, Yokoya M, Chanvorachote P. A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway. Chemical Research in Toxicology. 2025. doi:10.1021/acs.chemrestox.4c00436

BibTeX
@article{Soonthonsrima2025,
  author = {Soonthonsrima, Tanapon and Putra, Ismail Dwi and Phookphan, Preeyaphan and Ei, Zin Zin and Yokoya, Masashi and Chanvorachote, Pithi},
  title = {A Promising Resveratrol Analogue Suppresses CSCs in Non-Small-Cell Lung Cancer via Inhibition of the ErbB2 Signaling Pathway},
  journal = {Chemical Research in Toxicology},
  year = {2025},
  doi = {10.1021/acs.chemrestox.4c00436}
}
Kostenlos starten →